Discontinuation report TERAZOSIN
| Report ID | 151278 |
| Drug Identification Number | 02350475 |
| Brand name | TERAZOSIN |
| Common or Proper name | TERAZOSIN |
| Company Name | SANIS HEALTH INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TERAZOSIN |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-03-01 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-12-16 | French | Compare |
| v3 | 2021-12-16 | English | Compare |
| v2 | 2021-12-16 | French | Compare |
| v1 | 2021-12-16 | English | Compare |
Showing 1 to 4 of 4